Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer

Authors:

Abstract
No abstract available
Funding Information
  • Merck Sharp and Dohme United Kingdom
  • Pfizer
  • Biomedical Advanced Research and Development Authority
  • AstraZeneca
  • Astellas Pharma
  • Bristol-Myers Squibb
  • Hôpitaux Universitaires de Genève
  • Eli Lilly and Company
  • Roche